Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

Clinical trial NCT00751348 · COMPLETED

Trial details

NCT number: NCT00751348
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Measles Varicella Mumps Rubella

Start date: 2008-10-01
Primary completion: 2010-05-27
Enrollment: 475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.